Tag Archives: NOVAVAX SAYS OMICRON SHOT SHOWS STRONG IMMUNE RESPONSE AS SECOND BOOSTER

Vaccine maker Novavax Inc said on Tuesday its COVID-19 shot retooled against the Omicron BA.1 variant showed a strong immune response as the fourth dose and met the main goal of strain change in a late-stage study. Data showed the shot, NVX-CoV2515, produced 1.6 times the amount of neutralizing antibodies in people who had previously not been exposed to COVID-19 …

Read More »